MSD
The Value and Patient Access Manager will design and execute market access strategies, lead HTA submissions, and develop quantitative models to support access decisions. The role involves translating complex data into strategic insights, monitoring health policy changes, and building stakeholder engagement platforms within an international environment.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
MSD didn’t post a salary, so this is our estimate from similar listings.
32% below the average for this role
MSD ends takeover talks with Revolution Medicines
1 month ago
Director, International Value & Access
Denali Therapeutics
HTA Early Talent Programme: Market Access UK – Graduate Level (MSC)
AbbVie
Director, Value Demonstration & Access Evidence Strategy (Hematology)
BeOne Medicines
Value & Access Analyst
Novartis
Value & Access Analyst
Novartis
Health Technology Assessment (HTA) Consultant
IQVIA